Welcome to Tangshan Moneide Trading Co., Ltd.
Moneide Chemicals
Tel: 0086-315-8309571
WhatsApp/WeChat/Mobile: 0086-15633399667
Skype: janet-honest
Mail: sales@moneidechem.com
Address: 2-7-523 Jidong Building Materials Commercial Center, Tangshan, Hebei 064000 China
High-Quality 4 Methyldiphenylamine | Drug Intermediate Supplier
- Time of issue:Sep . 19, 2025 20:45
(Summary description)Tangshan Moneide Trading Co., Ltd. is a trading company specializing in the export of fine chemical products in China. Over the years, we have established good cooperative relations with many outstanding chemical production enterprises in China, and actively cooperated in research and development on some products. Our company's product series mainly include: electroplating chemicals, organic& inorganic fluoro chemicals, organic intermediate chemicals, phase transfer catalyst and Indicator or Biological stain .
- Categories:Company dynamic
- Author:
- Origin:
- Time of issue:2019-12-30 10:55
- Views:
In the complex landscape of pharmaceutical and specialty chemical synthesis, the purity and reliability of intermediates are paramount.
4-Methyldiphenylamine
stands out as a vital compound, playing a crucial role as a `drug substance intermediate` in the production of various active pharmaceutical ingredients (APIs) and fine chemicals. Its unique chemical structure and reactivity make it indispensable across multiple synthetic pathways, impacting the efficacy and safety of final drug products. Moneide Chem specializes in delivering high-purity
4-Methyldiphenylamine as part of our comprehensive portfolio of `bulk drugs and intermediates`, ensuring pharmaceutical-grade quality for our global partners.
The demand for high-quality intermediates like
4-Methyldiphenylamine is consistently growing, driven by advancements in medicinal chemistry and stringent regulatory requirements. As pharmaceutical companies strive for greater specificity and reduced side effects in their drug formulations, the quality of starting materials directly correlates with the success of their R&D and manufacturing efforts. Our commitment at Moneide Chem is to provide
4-Methyldiphenylamine that meets and exceeds international standards, offering exceptional batch consistency and a robust supply chain to support critical projects.
The global market for `bulk drugs and intermediates`, including compounds like
4-Methyldiphenylamine, is characterized by several key trends. Firstly, there's an undeniable shift towards more sustainable and green chemistry practices. Manufacturers are increasingly seeking intermediates produced through environmentally friendly processes, reducing solvent use, energy consumption, and waste generation. This trend is not merely regulatory-driven but also reflects a growing corporate responsibility.
Secondly, supply chain resilience has become a paramount concern, particularly after recent global disruptions. Companies are diversifying their sourcing strategies, looking for reliable partners with robust manufacturing capabilities and geographic flexibility. This has led to an increased emphasis on transparent supply chains and comprehensive quality control from raw material to finished intermediate.
Thirdly, technological advancements in synthetic methodologies, such as continuous flow chemistry and biocatalysis, are revolutionizing the production of intermediates. These innovations promise higher yields, improved purity, and reduced operational costs, driving down the overall cost of drug manufacturing while maintaining or enhancing quality. Moneide Chem actively invests in research and development to incorporate these cutting-edge techniques into our production of
4-Methyldiphenylamine, ensuring our clients benefit from the most efficient and advanced manufacturing processes available.
Understanding the precise technical specifications of
4-Methyldiphenylamine is critical for its effective integration into complex synthetic schemes. Our product is manufactured to exacting standards, ensuring high purity and consistent physiochemical properties. Key parameters such as molecular weight, melting point, assay purity, and impurity profile are rigorously controlled and documented.
These specifications are crucial for ensuring the compound's suitability for pharmaceutical synthesis, where even trace impurities can affect reaction kinetics, yield, or ultimately, the quality of the final API. Moneide Chem's analytical capabilities, including state-of-the-art HPLC, GC, and ICP-MS systems, guarantee that each batch of
4-Methyldiphenylamine adheres strictly to these critical parameters.
The production of high-purity
4-Methyldiphenylamine at Moneide Chem follows a rigorously controlled, multi-step synthetic pathway, optimized for yield, purity, and environmental sustainability. Our process integrates advanced chemical engineering principles with stringent quality control checkpoints, adhering to international standards such as ISO 9001:2015.
High-grade aniline and 4-methylchlorobenzene (or alternative substituted benzene derivatives) are sourced from approved suppliers. Each batch undergoes rigorous incoming QC testing for purity, moisture content, and identity before approval. This initial stage is crucial to prevent impurities from entering the main synthesis pathway. The core synthesis involves an optimized Ullmann-type coupling reaction between aniline and 4-methylchlorobenzene in the presence of a proprietary catalytic system. The reaction is conducted under controlled temperature and pressure conditions in a jacketed reactor, ensuring high selectivity and minimal by-product formation. Reaction parameters are continuously monitored via online process analytical technology (PAT). Upon completion of the reaction, the mixture is quenched to stop the reaction and remove catalyst residues. This typically involves aqueous workup, filtration, and solvent extraction steps. The crude
4-Methyldiphenylamine is then isolated. The crude product undergoes multiple purification steps, primarily recrystallization from carefully selected solvent systems. This process is critical for achieving the high purity levels required for pharmaceutical applications. The purified product is then thoroughly dried under vacuum to remove residual solvents, ensuring conformance to ICH Q3C guidelines for residual solvents. Each production batch undergoes a comprehensive final Quality Control (QC) battery, encompassing all parameters listed in the product specification table. This includes HPLC for purity, ICP-MS for heavy metals, and physical appearance checks. The product is then packaged in pharmaceutical-grade container111s under inert atmosphere to maintain stability and prevent contamination, ready for dispatch to target industries.
The versatility of
4-Methyldiphenylamine as a `drug substance intermediate` allows its application in diverse synthetic pathways for a range of critical products. Its reactivity as an aromatic amine and its specific structural features make it a valuable building block.
Moneide Chem's offering of
4-Methyldiphenylamine comes with distinct technical advantages that set it apart in the market, providing tangible benefits to our B2B clients in the `bulk drugs and intermediates` sector.
When selecting a supplier for critical `bulk drugs and intermediates` like
4-Methyldiphenylamine, B2B decision-makers weigh factors beyond mere price. Quality, reliability, and support are equally important. Here's a comparative overview:
This comparison highlights Moneide Chem's commitment to delivering superior quality and comprehensive support, which translates into reduced risks and greater operational efficiency for our clients. Our long-standing presence (over 15 years in the industry) and partnerships with leading pharmaceutical companies attest to our reliability and authority.
Moneide Chem understands that standard solutions don't always fit unique project requirements. We offer tailored manufacturing and supply solutions for
4-Methyldiphenylamine to meet specific client needs, from custom purity specifications to specialized packaging and delivery schedules.
A leading global pharmaceutical company (Client P) was developing a novel antipsychotic drug that required exceptionally high-purity
4-Methyldiphenylamine as a key `drug substance intermediate`. Their existing supplier struggled to consistently meet the
Solution: Our R&D team developed an optimized purification protocol specifically targeting the problematic impurity, leveraging advanced chromatographic techniques and a second-stage recrystallization. We successfully delivered multiple pilot batches of `4-Methyldiphenylamine` consistently exceeding 99.7% purity, with the critical impurity reduced to below the client's detection limits (
Outcome: Client P was able to significantly accelerate their Phase III clinical trials by ensuring the purity and consistency of their API. The enhanced purity from Moneide Chem also resulted in an estimated `energy saving` of 15% in Client P's downstream purification process due to reduced solvent consumption and shortened cycle times. This partnership demonstrated our capability not only to supply high-quality intermediates but also to provide innovative problem-solving and customized solutions for complex pharmaceutical challenges.
Our standard lead time for
4-Methyldiphenylamine ranges from 2-4 weeks, depending on order volume and current inventory levels. For urgent requirements or large-scale projects, we encourage clients to discuss their specific needs with our sales team for expedited fulfillment options.
Moneide Chem operates under a stringent Quality Management System certified to ISO 9001:2015. Our manufacturing facilities adhere to principles of current Good Manufacturing Practices (cGMP) as applicable for `drug substance intermediate` production, ensuring robust process control and documentation.
Absolutely. We specialize in customized solutions. We can provide additional analytical testing (e.g., specific impurity quantification, particle size analysis) and bespoke packaging arrangements (e.g., specific container111 sizes, inert atmosphere packaging) to meet your project's unique requirements. Please consult with our technical sales team for feasibility.
Our streamlined production and inventory management systems enable efficient `fulfillment` of orders. For standard quantities, we aim for delivery within the stipulated 2-4 week timeframe. Larger, custom, or contract orders will have a jointly agreed-upon schedule to align with project timelines, with regular updates provided throughout the manufacturing and logistics phases. Our global logistics network ensures timely and secure delivery.
Moneide Chem offers a comprehensive `warranty` that guarantees our
4-Methyldiphenylamine products will meet the specifications outlined in our Certificate of Analysis (CoA) for a period of 12 months from the date of manufacture, provided proper storage conditions are maintained. Our commitment to quality is backed by rigorous in-process and final product testing. In the rare event of a discrepancy, our quality assurance team will conduct a thorough investigation and work promptly to resolve the issue to your satisfaction.
Moneide Chem is dedicated to providing exceptional customer service and technical support. Our team of experienced chemists and sales professionals is available to assist with product inquiries, technical specifications, order status, and customized solutions.
We aim to respond to all inquiries within 24 business hours, ensuring that your projects proceed without unnecessary delays.
As a cornerstone `drug substance intermediate`, the quality of
4-Methyldiphenylamine directly influences the success of pharmaceutical synthesis and other specialty chemical applications. Moneide Chem is committed to being your trusted partner, providing high-purity, consistently reliable material backed by expert technical support and robust quality assurance. Our dedication to adherence to stringent industry standards ensures that we empower our clients to achieve their objectives with confidence.
Introduction to 4-Methyldiphenylamine: A Critical Pharmaceutical Intermediate
Industry Trends & Market Dynamics for Pharmaceutical Intermediates
Technical Specifications of 4-Methyldiphenylamine
Product Specification Table: 4-Methyldiphenylamine
Parameter
Specification
Testing Method
Chemical Name
N-(4-methylphenyl)aniline; 4-Methyldiphenylamine
N/A
CAS Number
637-04-7
N/A
Molecular Formula
C₁₃H₁₃N
N/A
Molecular Weight
183.25 g/mol
Calculated
Appearance
White to off-white crystalline powder
Visual Inspection
Purity (HPLC)
≥ 99.0%
HPLC-UV
Melting Point
89-92 °C
DSC
Loss on Drying
≤ 0.5%
KF Titration/Gravimetric
Residual Solvents
Conforms to ICH Q3C (R6)
GC-FID
Heavy Metals
≤ 10 ppm
ICP-MS
Detailed Manufacturing Process Flow of 4-Methyldiphenylamine
Process Flow Overview:
Application Scenarios of 4-Methyldiphenylamine
Technical Advantages & Moneide Chem's Value Proposition
Vendor Comparison: Moneide Chem vs. Market Alternatives
4-Methyldiphenylamine Supplier Comparison
Feature/Attribute
Moneide Chem
Generic Market Supplier A
Generic Market Supplier B
Purity (HPLC)
≥ 99.0% (Guaranteed)
98.0-99.0% (Typical)
97.0-98.5% (Variable)
Impurity Profile Control
Comprehensive, ICH Q3C compliant
Basic, limited data
Minimal data provided
Quality Management System
ISO 9001:2015 Certified, GMP Aligned
Basic internal QC
Unspecified
Regulatory Support
DMF Support, full documentation
Limited CoA
None
Customization Options
Yes, for specific purity/particle size
No
No
Supply Chain Reliability
Robust, multi-source, global logistics
Single source, regional
Intermittent, limited capacity
Customized Solutions & Service Case Studies
Customization Options:
Application Case Study: Accelerating API Development for a Global Pharma Client
Trustworthiness: FAQ, Lead Time, Warranty & Support
Frequently Asked Questions (FAQ)
Lead Time & Fulfillment
Warranty & Quality Assurance
Customer Support Information
Conclusion
References